Whitehawk Therapeutics Ratios (2018-2025) | WHWK

Ratios Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 92.24%90.08%86.03%95.75%90.98%89.42%88.30%85.35%87.82%87.41%88.85%89.09%89.36%
EBT Margin 61.26%-397,322.25%-1,251.52%57.29%-4,563.33%675.77%55,470.06%-114.21%-600.65%-531.28%-340.97%-266.35%-259.47%-245.45%-273.57%-257.18%-341.64%-235.98%-173.95%-252.42%-201.92%
EBIT Margin 59.49%-413,534.42%-1,152.81%60.03%-3,405.83%1,707.05%55,612.10%-113.89%-598.79%-534.19%-354.20%-296.00%-286.77%-315.14%-299.53%-280.02%-364.51%-252.21%-185.98%-261.76%-212.99%
EBITDA Margin 59.49%-413,534.42%-1,358.87%55.52%-3,405.83%1,707.05%55,470.06%-118.84%-600.65%-531.54%-343.30%-266.48%-258.05%-289.95%-273.10%-256.50%-342.31%-236.32%-173.04%-252.74%1,021.71%
Operating Margin 59.49%-413,534.42%-1,152.81%60.03%-3,405.83%1,707.05%55,612.10%-113.89%-598.79%-534.19%-354.20%-296.00%-286.77%-315.14%-299.53%-280.02%-364.51%-252.21%-185.98%-261.76%-212.99%
Net Margin 61.30%-397,322.29%-1,251.95%57.29%-4,563.33%675.77%55,470.06%-114.21%-600.65%-531.54%-340.97%-266.18%-259.47%-245.45%-273.57%-257.18%-341.64%-235.98%-173.95%-252.42%-201.92%
FCF Margin -33.17%-288,868.14%-6,833.24%-23.39%8,802.50%1,403.08%11,065.61%-89.10%-842.74%-318.80%-195.45%-217.87%-386.55%-281.31%-218.98%-165.35%-380.95%-156.95%-220.12%-210.51%-173.76%
Efficiency
Inventory Average 0.46M0.73M1.30M2.83M3.63M3.54M5.02M6.18M6.02M5.78M5.39M
Assets Average 42.14M69.85M67.14M59.59M52.33M47.58M42.74M37.82M40.71M47.77M34.33M29.99M39.29M103.10M163.34M150.11M135.48M161.37M189.17M177.45M160.94M145.44M136.04M121.75M106.35M93.66M78.01M152.16M207.41M173.92M
Equity Average 29.51M57.21M62.59M54.73M48.26M43.72M39.12M34.77M37.80M44.96M17.44M13.30M37.12M93.07M143.67M130.52M116.68M138.92M163.74M152.18M138.70M124.81M111.70M97.83M84.63M73.83M60.67M137.10M196.90M164.62M
Invested Capital 11.11M47.91M66.52M58.67M50.80M45.72M41.71M36.54M33.01M42.60M47.32M1.88M39.03M35.22M150.95M136.66M124.63M108.73M169.11M158.38M145.99M131.42M118.20M105.19M90.46M78.79M68.87M52.48M221.73M172.07M157.17M
Asset Utilization Ratio 0.960.480.360.130.080.110.140.150.080.110.130.160.180.200.220.270.330.18
Leverage & Solvency
Interest Coverage Ratio -11.6336.54-18.25-17.07-556.12-279.74-238.17-316.55-259.24-271.44-290.09-336.98-307.74-310.77-336.41-268.69-352.97
Debt to Equity -1.150.040.04
Debt Ratio 0.760.030.04
Equity Ratio 0.750.690.950.910.920.920.920.910.920.930.95-0.660.950.940.890.860.880.850.870.860.860.870.850.790.810.780.800.750.950.950.94
Times Interest Earned -11.6336.54-18.25-17.07-556.12-279.74-238.17-316.55-259.24-271.44-290.09-336.98-307.74-310.77-336.41-268.69-352.97
Valuation
Enterprise Value 115.16M43.88M56.58M6.39M-16.85M-11.22M-15.79M-13.22M-12.27M5.87M15.82M41.71M22.03M43.24M-68.08M355.60M225.33M139.27M113.96M140.43M25.75M32.26M-0.66M-59.30M-30.81M-42.72M-11.91M30.53M-147.79M-121.37M-197.72M
Market Capitalization 128.92M112.66M125.39M69.00M36.57M36.94M27.60M25.31M22.32M50.73M63.10M46.17M61.03M80.06M93.32M504.59M355.18M258.01M296.97M312.99M176.92M167.15M118.68M49.54M57.46M35.85M50.71M77.76M83.28M88.09M89.54M
Return Ratios
Return on Sales -0.11%-0.30%-0.13%-6.27%-8.01%-7.44%-6.90%-2.61%-3.98%-3.30%-2.73%-2.61%-2.59%-2.77%-2.75%-2.46%-2.45%-2.15%
Return on Capital Employed -0.25%-0.17%-0.45%-0.71%-0.09%-0.06%-0.95%-0.75%-0.87%-1.10%-0.44%-0.37%-0.41%-0.45%-0.56%-0.66%-0.73%-0.84%-0.85%-1.11%-0.45%-0.52%-0.66%
Return on Assets -0.21%-0.14%-0.42%-0.10%-0.14%-0.05%-0.83%-0.67%-0.79%-1.00%-0.39%-0.32%-0.35%-0.37%-0.42%-0.46%-0.54%-0.62%-0.66%-0.82%-0.39%-0.47%-0.59%
Return on Equity -0.23%-0.15%-0.45%-0.20%-0.33%-0.05%-0.92%-0.77%-0.91%-1.16%-0.45%-0.37%-0.41%-0.42%-0.49%-0.56%-0.68%-0.77%-0.84%-1.05%-0.44%-0.50%-0.63%